InvestorsHub Logo
Followers 9
Posts 917
Boards Moderated 0
Alias Born 05/12/2005

Re: None

Thursday, 06/27/2019 12:06:33 AM

Thursday, June 27, 2019 12:06:33 AM

Post# of 467765
Anyone have any thoughts on a Takeda partnership over Esiai? Does anyone lean more Takeda or Eisai?

Steffen Thomas, PhD, a director of Anavex®, has over 15 years of experience as a European patent attorney and is currently practicing at Epping Hermann Fischer, a major intellectual property law firm in Europe. Previously, he worked for Japan-based Takeda Pharmaceutical Company, the largest pharmaceutical company in Asia and a top firm worldwide, as an in-house patent attorney. Prior to that, he worked for Nycomed Pharma, acquired by Takeda in 2011 for approximately USD $10 billion. Dr. Thomas’ legal practice covers drafting of patent applications, prosecuting patent applications before national and international patent offices, defending and challenging patents in opposition, appeal, and nullity proceedings, enforcing patents before the infringement courts, and preparing opinions on patentability and infringement in the technical field of chemistry. Dr. Thomas has particular expertise in small molecule pharmaceuticals. He holds MS and PhD degrees in Chemistry from the University of Munich.


https://www.anavex.com/our-team/

Also there are lots of "German" connections..From Dr M and others on the Team. Haven't heard Roche name linked up yet. Thoughts?

https://en.wikipedia.org/wiki/Hoffmann-La_Roche
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News